These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 3329700)

  • 1. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
    Khudoley V; Malaveille C; Bartsch H
    Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
    Bartsch H; Malaveille C; Tomatis L; Brun G; Dodet B; Terracini B
    IARC Sci Publ; 1982; (41):525-32. PubMed ID: 6754595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella.
    Raineri R; Poiley JA; Andrews AW; Pienta RJ; Lijinsky W
    J Natl Cancer Inst; 1981 Nov; 67(5):1117-22. PubMed ID: 6946249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinogenicity of N-nitroso compounds].
    Montesano R
    Ann Nutr Aliment; 1976; 30(5-6):867-71. PubMed ID: 1030226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenicity and mutagenicity testing of three isomeric N-nitroso-N-methylaminopyridines in rats.
    Preussmann R; Habs M; Pool BL
    J Natl Cancer Inst; 1979 Jan; 62(1):153-6. PubMed ID: 364151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
    Lijinsky W; Andrews AW
    Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species specificity in the metabolism of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine to mutagens by isolated rat and hamster hepatocytes.
    Mangino MM; Hollenberg PF; Scarpelli DG
    Cancer Res; 1987 Sep; 47(18):4776-81. PubMed ID: 3113724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Butylhydroxytoluene inhibition of the mutagenic activity of carcinogenic nitroso compounds and cyclophosphamide: the role of the glutathione conjugation reaction].
    Kalinina EV; Loknitskaia NN; Shuliakovskaia TS; Fonshteĭn LM
    Vopr Onkol; 1987; 33(9):59-63. PubMed ID: 3310399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds.
    Nagao M; Suzuki E; Yasuo K; Yahagi T; Seino Y
    Cancer Res; 1977 Feb; 37(2):399-407. PubMed ID: 318920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and mutagenicity of N-nitroso-2-methoxy-2,6-dimethylmorpholine in hamsters.
    Gingell R; Brunk G; Nagel D; Wallcave L; Walker B; Pour P
    J Natl Cancer Inst; 1980 Jan; 64(1):157-61. PubMed ID: 6928040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directly-acting mutagens formed from N-nitroso-N-(formylmethyl)alkylamines.
    Suzuki E; Osabe M; Mochizuki M; Okada M
    IARC Sci Publ; 1987; (84):100-3. PubMed ID: 3315995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation and deactivation of mutagens and carcinogens.
    De Flora S
    Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free radicals in arylamine carcinogenesis.
    Floyd RA
    Natl Cancer Inst Monogr; 1981 Dec; (58):123-31. PubMed ID: 6281648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vivo and in vitro studies of mutagenic properties of carcinogenic N-nitramines].
    Khudoleĭ VV; Malaveille C; Bartsch H
    Vopr Onkol; 1981; 27(11):59-62. PubMed ID: 7039103
    [No Abstract]   [Full Text] [Related]  

  • 18. Participation of phenobarbital-inducible cytochrome P450 in the mutagenic activation of N-nitrosopropylamines by liver and lung 9000 g fractions from five animal species and man.
    Mori Y; Konishi Y
    IARC Sci Publ; 1991; (105):398-403. PubMed ID: 1855888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.
    Mochizuki M; Osabe M; Anjo T; Takeda K; Suzuki E; Okada M
    IARC Sci Publ; 1984; (57):715-9. PubMed ID: 6398304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by fatty acids of direct mutagenicity of N-nitroso compounds.
    Takeda K; Ukawa S; Mochizuki M
    IARC Sci Publ; 1991; (105):558-63. PubMed ID: 1855917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.